DFDA

Oral Naltrexone

Treatment for Alcohol Use Disorders

Typical Dosage: 50mg daily

Effectiveness
35%
Safety Score
62%
Clinical Trials
14
Participants
18K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
62
DangerousModerateSafe
Treatment Details
Dosage Range
50mg daily
Time to Effect
1-2 weeks
Treatment Duration
3-12 months
Evidence Quality
HIGH
Number Needed to Treat (NNT)
10(Treat 10 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$750
Side Effect Mgmt:$100
Total Annual:$1,350
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$30,000/QALY
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$3,857
Cost per Remission
$6,750
Prescription Access Economics
Risk Assessment
Misuse Risk
LOW
Missed Diagnosis Risk
LOW
Requires Monitoring
Yes
Needs lab work/checkups
Oral Naltrexone Outcomes

for Alcohol Use Disorders

Efficacy Outcomes
Overall Effectiveness
+35%
Response Rate
+35%
Remission Rate
+20%
Common Side Effects
Nausea
+15%
Headache
+10%
Dizziness
+7%
Fatigue
+7%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
4 active trials recruiting for Oral Naltrexone in Alcohol Use Disorders

Emergency Department-Initiated Medications for Alcohol Use Disorder

NCT05827159RECRUITINGPHASE3
View Study
240 participants
INTERVENTIONAL
New Haven, United States
Started: Aug 17, 2024

Sex Differences in Trauma, Inflammation and Brain Function and the Implications for Treatment Efficacy in Alcohol Use Disorder

NCT06426303RECRUITINGPHASE4
View Study
100 participants
INTERVENTIONAL
Portland, United States
Started: May 2, 2024

Combination Therapy for Alcohol Use Disorder

NCT07249554NOT YET RECRUITINGPHASE2
View Study
45 participants
INTERVENTIONAL
Havre de Grace, United States
Started: Sep 1, 2026

Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol

NCT07269873RECRUITINGPHASE1
View Study
30 participants
INTERVENTIONAL
Miami, United States
Started: Mar 16, 2026
Completed Clinical Trials
10 completed trials for Oral Naltrexone in Alcohol Use Disorders

ED Initiated Oral Naltrexone for AUD

NCT04817410COMPLETEDPHASE1
View Study
30 participants
INTERVENTIONAL
New York, United States
Started: Sep 28, 2021

Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder

NCT01377168COMPLETEDPHASE4
View Study
159 participants
INTERVENTIONAL
Lima, Peru
Started: May 1, 2014

Alcohol Disorder hOsPital Treatment Trial

NCT02478489COMPLETEDPHASE4
View Study
248 participants
INTERVENTIONAL
Boston, United States
Started: Jun 1, 2016

Treatment Strategy for Alcohol Use Disorders in Veterans With TBI

NCT01342549COMPLETEDPHASE3
View Study
62 participants
INTERVENTIONAL
Iowa City, United States +1 more
Started: Sep 1, 2011

Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder

NCT05093296COMPLETEDPHASE2, PHASE3
View Study
62 participants
INTERVENTIONAL
Mannheim, Germany
Started: Dec 2, 2021

Effectiveness of Alcohol Interventions Among Tuberculosis (TB) Patients in Tomsk Oblast, Russia

NCT00675961COMPLETEDNA
View Study
400 participants
INTERVENTIONAL
Tomsk, Russia
Started: Jan 1, 2007

Targeted Naltrexone for Problem Drinkers

NCT00369408COMPLETEDPHASE4
View Study
163 participants
INTERVENTIONAL
Farmington, United States
Started: Jun 1, 2003

Integrated Digital Intervention for Alcohol Use Disorder

NCT05748639COMPLETEDPHASE2, PHASE3
View Study
242 participants
INTERVENTIONAL
New York, United States
Started: Jan 1, 2023

Medication and Counseling for Controlled Drinking (Project SMART)

NCT00444418COMPLETEDPHASE3
View Study
200 participants
INTERVENTIONAL
New York, United States
Started: Apr 1, 2006

MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study

NCT03718104COMPLETED
View Study
46 participants
OBSERVATIONAL
Boston, United States +1 more
Started: Dec 1, 2018